Gotham Asset Management LLC acquired a new position in shares of Imperva Inc (NYSE:IMPV) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 8,709 shares of the software maker’s stock, valued at approximately $358,000.
Several other large investors have also modified their holdings of IMPV. Highbridge Capital Management LLC acquired a new stake in shares of Imperva during the first quarter worth about $306,000. Ionic Capital Management LLC purchased a new position in Imperva during the first quarter worth $6,460,000. State Street Corp boosted its position in Imperva by 2.6% in the first quarter. State Street Corp now owns 532,533 shares of the software maker’s stock worth $21,859,000 after buying an additional 13,390 shares during the period. Bank of America Corp DE boosted its position in Imperva by 2.0% in the first quarter. Bank of America Corp DE now owns 513,056 shares of the software maker’s stock worth $21,061,000 after buying an additional 9,814 shares during the period. Finally, Weiss Multi Strategy Advisers LLC boosted its position in Imperva by 127.3% in the first quarter. Weiss Multi Strategy Advisers LLC now owns 25,000 shares of the software maker’s stock worth $1,026,000 after buying an additional 14,000 shares during the period. 92.72% of the stock is owned by hedge funds and other institutional investors.
Shares of Imperva Inc (NYSE IMPV) opened at 49.45 on Wednesday. The stock’s market cap is $1.65 billion. The company has a 50-day moving average of $49.16 and a 200 day moving average of $43.54. Imperva Inc has a 52-week low of $34.40 and a 52-week high of $57.24.
Imperva (NYSE:IMPV) last issued its quarterly earnings data on Thursday, May 4th. The software maker reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.33. Imperva had a net margin of 31.92% and a return on equity of 36.67%. The business had revenue of $72.31 million for the quarter, compared to analysts’ expectations of $68.16 million. During the same period in the previous year, the business earned ($0.25) earnings per share. The company’s revenue was up 21.0% on a year-over-year basis. Equities research analysts forecast that Imperva Inc will post $0.45 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was originally posted by BBNS and is owned by of BBNS. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://baseballnewssource.com/markets/gotham-asset-management-llc-invests-358000-in-imperva-inc-nyseimpv/1180404.html.
A number of research firms recently weighed in on IMPV. ValuEngine cut shares of Imperva from a “hold” rating to a “sell” rating in a research note on Tuesday. Imperial Capital restated an “outperform” rating and set a $57.00 target price (up previously from $55.00) on shares of Imperva in a research note on Tuesday, May 9th. Royal Bank Of Canada lifted their target price on shares of Imperva from $52.00 to $55.00 and gave the company an “outperform” rating in a research note on Friday, May 5th. Zacks Investment Research cut shares of Imperva from a “buy” rating to a “hold” rating in a research note on Tuesday, May 9th. Finally, Monness Crespi & Hardt lifted their target price on shares of Imperva from $52.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, May 5th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have given a buy rating to the stock. Imperva presently has a consensus rating of “Hold” and a consensus target price of $48.85.
In other news, insider Amichai Shulman sold 3,085 shares of the stock in a transaction on Monday, April 17th. The stock was sold at an average price of $41.97, for a total transaction of $129,477.45. Following the sale, the insider now owns 99,151 shares in the company, valued at $4,161,367.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CRO Michael D. Mooney sold 52,356 shares of the stock in a transaction on Wednesday, May 10th. The stock was sold at an average price of $47.51, for a total value of $2,487,433.56. Following the sale, the executive now owns 52,356 shares in the company, valued at approximately $2,487,433.56. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 63,387 shares of company stock worth $3,005,338. Company insiders own 2.20% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with our FREE daily email newsletter.